FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5


1. Name and Address of Reporting Person * Gorsky Alex 2. Issuer Name and Ticker or Trading Symbol JOHNSON & JOHNSON [ JNJ ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __ X __ Director _____ 10% Owner
__ X __ Officer (give title below) _____ Other (specify below)
Chairman, CEO
ONE JOHNSON & JOHNSON PLAZA 3. Date of Earliest Transaction (MM/DD/YYYY)
NEW BRUNSWICK, NJ 08933 4. If Amendment, Date Original Filed (MM/DD/YYYY) 6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock11/16/2018M144695.0000A$62.2000481254.0000D
Common Stock11/16/2018M119770.0000A$62.6200601024.0000D
Common Stock11/16/2018S264465.0000D$145.9587(1)336559.0000D
Common Stock495.0000(2)IBy 401k
Common Stock1074.0000(3)IBy ESOP
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Options (Right to Buy)$62.200011/16/2018M144695.00001/11/20141/8/2021Common Stock144695.0000$0.00000.0000D
Employee Stock Options (Right to Buy)$62.620011/16/2018M119770.00002/9/20132/7/2020Common Stock119770.0000$0.00000.0000D

Explanation of Responses:
(1) This transaction was executed in multiple trades at prices ranging from $145.73 to $146.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
(2) Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (10/31/2018).
(3) Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (10/31/2018).

Reporting Owners
Reporting Owner Name / Address
Director 10% Owner Officer Other
Gorsky Alex
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933
XChairman, CEO

Signatures
Linda E. King, as attorney-in-fact for Alex Gorsky11/16/2018
** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Attachments

  • Original document
  • Permalink

Disclaimer

Johnson & Johnson published this content on 16 November 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 17 November 2018 00:53:06 UTC